HEMATOLOGY TRANSFUSION AND CELL THERAPY : Impact Factor & More
eISSN: 2531-1379pISSN: 2531-1379
Share this on:
Key Metrics
SJR 
Q4Hematology
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on HEMATOLOGY TRANSFUSION AND CELL THERAPY
HEMATOLOGY TRANSFUSION AND CELL THERAPY Journal Specifications
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2018 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Publication ID scheme | DOI |
View less
Planning to publish in HEMATOLOGY TRANSFUSION AND CELL THERAPY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in HEMATOLOGY TRANSFUSION AND CELL THERAPY
In vitro compatibility of whole blood with commonly used medications in the pediatric trauma setting.
- 6 Aug 2026
- Hematology, transfusion and cell therapy
Association between serum biomarkers and clinical stage in treatment-naïve chronic lymphocytic leukemia.
- 6 Aug 2026
- Hematology, transfusion and cell therapy
Evaluation of salivary flow in patients following hematopoietic stem cell transplantation: a retrospective study.
- 6 Aug 2026
- Hematology, transfusion and cell therapy
A rare large homozygous deletion of the HFE gene in a patient with hemochromatosis: a case report.
- 6 Aug 2026
- Hematology, transfusion and cell therapy
CD30 expression in diffuse large B-cell lymphoma and primary mediastinal lymphoma: frequency, association with prognostic factors, and impact on survival.
- 5 Aug 2026
- Hematology, transfusion and cell therapy
Improving engraftment in autologous hematopoietic stem cell transplantation: comparing pegfilgrastim with filgrastim in an outpatient setting.
- 30 Jul 2026
- Hematology, transfusion and cell therapy
In vitro compatibility of whole blood with commonly used medications in the pediatric trauma setting.
- 6 Aug 2026
- Hematology, transfusion and cell therapy
Association between serum biomarkers and clinical stage in treatment-naïve chronic lymphocytic leukemia.
- 6 Aug 2026
- Hematology, transfusion and cell therapy
Evaluation of salivary flow in patients following hematopoietic stem cell transplantation: a retrospective study.
- 6 Aug 2026
- Hematology, transfusion and cell therapy
A rare large homozygous deletion of the HFE gene in a patient with hemochromatosis: a case report.
- 6 Aug 2026
- Hematology, transfusion and cell therapy
CD30 expression in diffuse large B-cell lymphoma and primary mediastinal lymphoma: frequency, association with prognostic factors, and impact on survival.
- 5 Aug 2026
- Hematology, transfusion and cell therapy
Improving engraftment in autologous hematopoietic stem cell transplantation: comparing pegfilgrastim with filgrastim in an outpatient setting.
- 30 Jul 2026
- Hematology, transfusion and cell therapy
FAQs on HEMATOLOGY TRANSFUSION AND CELL THERAPY
How long has HEMATOLOGY TRANSFUSION AND CELL THERAPY been actively publishing? 
What is the publishing frequency of HEMATOLOGY TRANSFUSION AND CELL THERAPY?
How many articles did HEMATOLOGY TRANSFUSION AND CELL THERAPY publish last year?
What is the eISSN & pISSN for HEMATOLOGY TRANSFUSION AND CELL THERAPY?
What is the SJR for HEMATOLOGY TRANSFUSION AND CELL THERAPY?
Who is the publisher of HEMATOLOGY TRANSFUSION AND CELL THERAPY?
